Results 11 to 20 of about 3,000,774 (406)

Neuroendocrine Tumors [PDF]

Journal of the National Comprehensive Cancer Network, 2012
Neuroendocrine tumors (NETs) originate from single or clustered neuroendocrine cells, distributed in the gastrointestinal tract, urogenital tract, endocrine, and bronchopulmonary system. NETs account for approximately 2.2% of all malignancies. These slow growing tumors are difficult to localize and often metastatic at diagnosis. Surgery can be curative
Bodei L, Boni G, Paganelli G, VOLTERRANI, DUCCIO   +3 more
  +9 more sources

Chemotherapy in Neuroendocrine Tumors [PDF]

Cancers, 2021
The role for cytotoxic chemotherapy in patients with well-differentiated neuroendocrine tumors (NETs) remains debated. Compared to patients with poorly differentiated neuroendocrine carcinomas (NECs) where chemotherapy is utilized ubiquitously, chemotherapy may play a more select role in patients with certain types of NETs (e.g., pancreatic tumors ...
Satya Das, Taymeyah Al-Toubah, Jonathan Strosberg   +2 more
openaire   +3 more sources

Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues

Biomedicines, 2023
Angiogenic factors (AF) promote vascular formation and may thus support neuroendocrine tumour (NET) development. This study aimed to assess AF serum level changes in NET patients treated with prolonged-acting somatostatin analogues (SSAs).
Violetta Rosiek, Ksenia Janas, Beata Kos-Kudła   +2 more
doaj   +1 more source

Small-Cell Carcinoma of Nasopharynx: A Case Report of Unusual Localization [PDF]

, 2020
Neuroendocrine tumors are a spectrum of rare and highly heterogeneous neoplasms with distinct functional and biological behavior in relation to location, tumor size, and histological differentiation.
Allosso, Salvatore, Buono, Sarah, Mesolella, Massimo, Motta, Gaetano, Pignatiello, Sara, Russo, Daniela, Varricchio, Silvia   +6 more
core   +5 more sources

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2021
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas ...
M. Shah, W. Goldner, A. Benson, E. Bergsland, L. Blaszkowsky, P. Brock, J. Chan, Satya Das, P. Dickson, P. Fanta, T. Giordano, T. Halfdanarson, D. Halperin, Jin He, A. Heaney, M. J. Heslin, F. Kandeel, A. Kardan, S. Khan, B. Kuvshinoff, C. Lieu, Kimberly J. Miller, V. Pillarisetty, D. Reidy, S. A. Salgado, Shagufta Shaheen, H. Soares, M. Soulen, J. Strosberg, C. Sussman, N. Trikalinos, Nataliya A Uboha, Namrata Vijayvergia, T. Wong, B. Lynn, Cindy Hochstetler   +35 more
semanticscholar   +1 more source

Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE)

Biomedicines, 2023
The coronavirus disease-19 (COVID-19) pandemic dramatically impacted oncological patients’ care. Since the introduction of vaccines and the demonstration of their benefit on frail patients, COVID-19 vaccinations were indicated to also be beneficial to ...
Alice Laffi, Lorenzo Gervaso, Oriana D’Ecclesiis, Sara Gandini, Agostino Riva, Rita Passerini, Francesca Spada, Stefania Pellicori, Manila Rubino, Chiara Alessandra Cella, Paola Simona Ravenda, Maria Giulia Zampino, Nicola Fazio   +12 more
doaj   +1 more source

Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors:Functionality matters [PDF]

, 2021
Background: Metastasized pancreatic neuroendocrine tumors are the leading cause of death in patients with multiple endocrine neoplasia type 1. Aside from tumor size, prognostic factors of pancreatic neuroendocrine tumors are largely unknown.
, , , Borel Rinkes, Inne H.M., Nell, Sjoerd, Valk, Gerlof D., van Beek, Dirk Jan, Verkooijen, Helena M., Vriens, Menno R.   +8 more
core   +2 more sources

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance

Endocrine Connections, 2022
Objective: Up to now, serial NETest measurements in individuals assessing the disease course of gastroenteropancreatic neuroendocrine tumors (GEPNETs) at long-term follow-up and treatment response were not studied.
Mark J C van Treijen, Catharina M Korse, Wieke H Verbeek, Margot E T Tesselaar, Gerlof D Valk   +4 more
doaj   +1 more source

Risk of malignancy in adrenal tumors in patients with a history of cancer

Frontiers in Oncology, 2023
PurposeAdrenal gland is a common site of metastasis and on the other hand, metastases are the most frequent malignant adrenal tumors. The aim of this study was to estimate the risk of malignancy in suspicious adrenal mass in patients with a history of ...
Radosław Samsel, Karolina Nowak, Lucyna Papierska, Edyta Karpeta, Edyta Karpeta, Katarzyna Roszkowska-Purska, Wacław Smiertka, Tomasz Ostrowski, Eryk Chrapowicki, Alan Grabowski, Dorota Leszczyńska, Andrzej Cichocki   +11 more
doaj   +1 more source

Neuroendocrine Tumors of the Thymus [PDF]

Thoracic Surgery Clinics, 2011
Neuroendocrine tumors of the thymus (NETTs) are unusual thymic neoplasms that were misdiagnosed as thymomas until the 1970s, when they eventually acquired a distinct identity. No collective large series have been published so far, and information about clinical presentation, diagnosis, histology, and treatment is derived from analysis of the case ...
RUFFINI, Enrico, OLIARO, Alberto, Novero D, Campisi P, FILOSSO, Pier Luigi   +4 more
openaire   +3 more sources